Smac mimetic enables the anticancer action of BCG-stimulated neutrophils through TNF-α but not through TRAIL and FasL.
about
Immune Cells in Cancer Therapy and Drug DeliveryNovel PKC-ζ to p47 phox interaction is necessary for transformation from blebbishieldsRalBP1 and p19-VHL play an oncogenic role, and p30-VHL plays a tumor suppressor role during the blebbishield emergency program.Sequential intravesical mitomycin plus Bacillus Calmette-Guérin for non-muscle-invasive urothelial bladder carcinoma: translational and phase I clinical trialImmunological basis in the pathogenesis and treatment of bladder cancerEndocytosis and serpentine filopodia drive blebbishield-mediated resurrection of apoptotic cancer stem cells.Potential therapeutic anti-tumor effect of a Salmonella-based vaccine.Lenalidomide augments the efficacy of bacillus Calmette-Guerin (BCG) immunotherapy in vivo.Immune therapies in non-muscle invasive bladder cancer.Surface PD-L1, E-cadherin, CD24, and VEGFR2 as markers of epithelial cancer stem cells associated with rapid tumorigenesisPim kinase isoforms: devils defending cancer cells from therapeutic and immune attacks.Cooperative TRAIL production mediates IFNα/Smac mimetic-induced cell death in TNFα-resistant solid cancer cells.Blebbishield emergency program: an apoptotic route to cellular transformation.Hyperosmotic stress enhances cytotoxicity of SMAC mimetics.Redirecting neutrophils against bladder cancer cells by BCG and Smac mimetic combination.Mitochondrial oligomers boost glycolysis in cancer stem cells to facilitate blebbishield-mediated transformation after apoptosis.Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-α-independent mechanism.Molecular genetics and cellular events of K-Ras-driven tumorigenesis.CF3DODA-Me induces apoptosis, degrades Sp1, and blocks the transformation phase of the blebbishield emergency program.Expert consensus document: Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer.Blebbishields and mitotic cells exhibit robust macropinocytosis.
P2860
Q26747061-D847E4FE-582B-4D14-8D8C-E4D10459DAB7Q28116088-BA65F5EC-6E8B-4D7B-ADEF-141C0C665580Q33292271-FBCEE385-9D2D-4266-ACBE-EBFBC9AB2A13Q34979760-D8BF80DB-832C-42E0-8D63-8D0565CC7886Q36260118-D869A8AE-8FD0-4E4A-9DB9-460BBA706F97Q36926955-48FAF501-EF64-4B21-936B-546BDBFC9FA3Q37530067-1E2C80DC-20A2-4833-9B66-2E53F8B298C8Q37561393-23A9D29C-9CBB-4560-8827-A76B9245B5D6Q38372571-02ECDF1C-CE72-4584-8BCB-DCA18EA28066Q38635929-7F4063B5-76E5-46D9-BF1D-573CBFCE5FCEQ38960311-3D9BC681-5CF0-4F4C-91F1-CEFE702BD252Q39996056-A78CA435-182D-41D2-B806-AFC4332E7D98Q40187206-F0043E13-6D5E-4F62-A2C8-7F6A9BE522FBQ41169934-41D85178-9A4C-4BE0-B63F-28FAAE3EA490Q41275498-6EC973EB-2460-4E47-BF80-9C861285DE1BQ41767236-F0E5C925-586A-4744-8D4C-CE4F39331F64Q42713862-CF408B1C-8C67-41FE-9FCE-3F74FFADAEE8Q46277416-DCC22D89-C2A0-4983-9C0D-258DFABE1FBAQ46405590-2B4DBFF5-9F86-4519-8B21-E186CD665186Q46851166-FC9C182C-5D19-4BE9-BAF5-2A3F13450884Q52847065-FA5C60DD-C0E1-48EF-9A25-98E8AF39B928
P2860
Smac mimetic enables the anticancer action of BCG-stimulated neutrophils through TNF-α but not through TRAIL and FasL.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Smac mimetic enables the antic ...... ut not through TRAIL and FasL.
@ast
Smac mimetic enables the antic ...... ut not through TRAIL and FasL.
@en
type
label
Smac mimetic enables the antic ...... ut not through TRAIL and FasL.
@ast
Smac mimetic enables the antic ...... ut not through TRAIL and FasL.
@en
prefLabel
Smac mimetic enables the antic ...... ut not through TRAIL and FasL.
@ast
Smac mimetic enables the antic ...... ut not through TRAIL and FasL.
@en
P2093
P2860
P356
P1476
Smac mimetic enables the antic ...... ut not through TRAIL and FasL.
@en
P2093
Ashish M Kamat
Goodwin Jinesh G
Srinivas Chunduru
P2860
P304
P356
10.1189/JLB.1211623
P577
2012-04-18T00:00:00Z